The State of Texas Attorney General Sues Acetaminophen Manufacturers Over Autism Spectrum Allegations

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the firms concealed potential risks that the medication created to children's brain development.

The court filing arrives thirty days after Donald Trump promoted an unverified association between using acetaminophen - alternatively called paracetamol - during pregnancy and autism spectrum disorder in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which once produced the drug, the sole analgesic recommended for expectant mothers, and Kenvue, which presently makes it.

In a official comment, he stated they "betrayed America by gaining financially from discomfort and marketing drugs regardless of the dangers."

The manufacturer asserts there is lacking scientific proof connecting Tylenol to autism.

"These corporations misled for generations, knowingly endangering millions to increase profits," the attorney general, from the Republican party, said.

The company said in a statement that it was "deeply concerned by the perpetuation of misinformation on the security of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its online platform, Kenvue also stated it had "continuously evaluated the pertinent research and there is insufficient valid information that demonstrates a proven link between using paracetamol and autism."

Groups acting on behalf of doctors and medical practitioners concur.

ACOG has said acetaminophen - the key substance in acetaminophen - is among limited choices for women during pregnancy to treat discomfort and elevated temperature, which can present serious health risks if ignored.

"In over twenty years of investigation on the use of paracetamol in gestation, not a single reputable study has successfully concluded that the consumption of acetaminophen in any trimester of gestation causes neurodevelopmental disorders in offspring," the association said.

The lawsuit mentions current declarations from the former administration in claiming the medication is reportedly hazardous.

Last month, Trump raised alarms from health experts when he advised pregnant women to "resist strongly" not to take Tylenol when ill.

The US Food and Drug Administration then issued a notice that doctors should contemplate reducing the consumption of Tylenol, while also declaring that "a proven link" between the medication and autism spectrum disorder in young ones has not been established.

Health Secretary Kennedy, who manages the FDA, had pledged in spring to conduct "a massive testing and research effort" that would identify the source of autism spectrum disorder in a matter of months.

But specialists advised that discovering a unique factor of autism - thought by researchers to be the consequence of a complex mix of genetic and environmental factors - would not be simple.

Autism is a category of enduring cognitive variation and condition that impacts how persons experience and relate to the environment, and is identified using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is campaigning for the Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the firms "eliminate any promotional materials" that claims Tylenol is secure for pregnant women.

This legal action mirrors the complaints of a group of guardians of children with autism spectrum disorder and ADHD who took legal action against the manufacturers of Tylenol in 2022.

The court rejected the legal action, stating investigations from the parents' expert witnesses was lacking definitive proof.